Some lncRNAs may serve as biomarkers for cancer detection, metastasis and survival of patients [129], and the prostate cancer specific lncRNA, prostate cancer antigen 3 (PCA3) is an FDA approved lncRNA biomarker for prostate cancer detection [130]. This evidence concerns the gene PCA3 and Familial prostate cancer.